- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05521815
Effect of Early Coma Arousal Therapy on Conscious Level Recovery and Cognition in Traumatic Brain Injury
PURPOSE:
The aim of this study is to investigate the effect of early coma arousal therapy on conscious level and cognitive function in sever traumatic brain injury patients.
BACKGROUND:
Traumatic brain injury (TBI) could be simply defined as an alteration in brain function due to external forces and is considered as one of the leading cause of death and disability worldwide, especially among young adults and the elderly. Current estimates imply that annual incidence of TBI is 50-60 million worldwide, and specifically for Europe and USA, 0.5% of Europeans and 1.1% of Americans are experiencing a TBI each year.
The original scale has since been revised and is known as the Rancho Los Amigos Revised Scale (RLAS-R). One of the limitations of the original eight level scale was that it did not accurately reflect the individuals with higher levels of recovery. Two more levels were added to the initial eight level Ranchos Scale to create a more comprehensive ten level scale named the Rancho Los Amigos Revised Scale (RLAS-R).
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt
- Kasr El Aini Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion criteria:
- Both genders.
- Traumatic brain injury with GCS score 3-12.
- Age range from 20-50 years old.
- Must be medically stable post trauma 29
Exclusion Criteria:
- Patient with other neurological deficits or orthopedic abnormalities that causing disability.
- Patients with pre injury psychiatric disorders.
- Patients with pre injury cognitive disorders.
- Patients who performed surgery post traumatic brain injury.
- Patients not taking the same medications.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Study group
The group that are going to receive the coma arousal therapy program
|
early coma arousal therapy program in addition to selected physical therapy program (positioning, breathing exercise, passive movement of the four limbs).
|
|
Placebo Comparator: Control group
This group will receive only traditional treatment program
|
selected physiotherapy program only (positioning, breathing exercise, passive movement of the four limbs).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
conscious level
Time Frame: One and half year
|
is defined as the state of awareness of the self and environment with appropriate arousal or wakefulness.
conscious level will be measured using glascow coma scale (GCS), which is a scale used to objectively describe the extent of impaired consciousness in all types of acute medical and trauma patients.
The highest possible GCS score is 15, and the lowest is 3.
A score of 15 means you're fully awake, responsive and have no problems with thinking ability or memory.
Generally, having a score of 8 or fewer means you're in a coma.
The lower the score, the deeper the coma is.
|
One and half year
|
|
Cognition
Time Frame: One and half year
|
'cognition' refers to all the processes by which the sensory input is transformed, reduced, elaborated, stored, recovered, and used.
It is concerned with these processes even when they operate in the absence of relevant stimulation, as in images and hallucinations.
cognition will be measured using Rancho Los Amigos Revised Scale (RLAS-R), its a scale used by both medical and rehabilitation providers to measure and track cognitive recovery after traumatic brain injury.
It is a 10-point scale where Level I indicates No response/total assistance and Level X indicates Purposeful, appropriate/ modified independent.
|
One and half year
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 54531
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.